Enzo Biochem Inc (ENZ)
1.07
+0.01
(+0.94%)
USD |
NYSE |
Apr 25, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Enzo Biochem Cash from Investing (Quarterly): -0.025M for Jan. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.025M |
| October 31, 2023 | -0.254M |
| July 31, 2023 | 101.17M |
| April 30, 2023 | -0.666M |
| January 31, 2023 | -0.869M |
| October 31, 2022 | -0.652M |
| July 31, 2022 | -0.369M |
| April 30, 2022 | 27.89M |
| January 31, 2022 | -1.241M |
| October 31, 2021 | -1.061M |
| July 31, 2021 | -1.604M |
| April 30, 2021 | -31.77M |
| January 31, 2021 | -0.506M |
| October 31, 2020 | -0.617M |
| July 31, 2020 | -1.451M |
| April 30, 2020 | -0.285M |
| January 31, 2020 | -0.16M |
| October 31, 2019 | -0.274M |
| July 31, 2019 | -0.572M |
| April 30, 2019 | -0.566M |
| January 31, 2019 | -5.973M |
| October 31, 2018 | -1.015M |
| July 31, 2018 | -0.267M |
| April 30, 2018 | -0.601M |
| January 31, 2018 | -0.615M |
| Date | Value |
|---|---|
| October 31, 2017 | -0.461M |
| July 31, 2017 | -0.331M |
| April 30, 2017 | -0.731M |
| January 31, 2017 | -0.173M |
| October 31, 2016 | -0.514M |
| July 31, 2016 | -0.122M |
| April 30, 2016 | -0.449M |
| January 31, 2016 | -0.451M |
| October 31, 2015 | -0.49M |
| July 31, 2015 | -0.583M |
| April 30, 2015 | -0.516M |
| January 31, 2015 | -0.394M |
| October 31, 2014 | -0.259M |
| July 31, 2014 | -0.309M |
| April 30, 2014 | -0.052M |
| January 31, 2014 | -0.158M |
| October 31, 2013 | -0.314M |
| July 31, 2013 | -0.127M |
| April 30, 2013 | -0.23M |
| January 31, 2013 | -0.279M |
| October 31, 2012 | -0.335M |
| July 31, 2012 | 9.642M |
| April 30, 2012 | -0.516M |
| January 31, 2012 | -1.307M |
| October 31, 2011 | -0.358M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-31.77M
Minimum
Apr 2021
101.17M
Maximum
Jul 2023
4.306M
Average
-0.569M
Median
Cash from Investing (Quarterly) Benchmarks
| Delcath Systems Inc | -19.67M |
| Star Equity Holdings Inc | -3.321M |
| Exact Sciences Corp | -66.77M |
| CytoSorbents Corp | -0.1359M |
| Progyny Inc | -93.41M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.938M |
| Cash from Financing (Quarterly) | -0.022M |
| Free Cash Flow | -45.92M |
| Free Cash Flow Per Share (Quarterly) | -0.1775 |
| Free Cash Flow to Equity (Quarterly) | -9.361M |
| Free Cash Flow to Firm (Quarterly) | -8.963M |
| Free Cash Flow Yield | -85.88% |